Kondo, Keiichi <br/><br/>
Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.  [electronic resource] 

 -  PLoS biology  Dec 2003 
 - E83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1545-7885 
<br/><br/><label>Standard No.: </label>10.1371/journal.pbio.0000083  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Clear Cell--genetics<br/>Alleles<br/>Animals<br/>Base Sequence<br/>Basic Helix-Loop-Helix Transcription Factors--antagonists & inhibitors<br/>Binding Sites<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Dimerization<br/>Down-Regulation<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Genetic Variation<br/>Humans<br/>Immunoblotting<br/>Kidney Neoplasms--genetics<br/>Mice<br/>Mice, Nude<br/>Molecular Sequence Data<br/>Neoplasm Transplantation<br/>Oxygen--metabolism<br/>Plasmids--metabolism<br/>Protein Binding<br/>Protein Structure, Tertiary<br/>RNA--chemistry<br/>RNA, Small Interfering--metabolism<br/>Retroviridae--genetics<br/>Von Hippel-Lindau Tumor Suppressor Protein--antagonists & inhibitors